You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1676 to 1700 of about 5877
Next 25
04/28/2016
Nate Brundage continues the fight against brain cancer
04/27/2016
NCI opens online platform to submit ideas about research for Cancer Moonshot
Experimental therapy for brain cancer developed by UCLA and Caltech could prevent drug resistance
Novocure’s Optune Now Available at More Than 360 Cancer Treatment Centers in the U.S.
Research findings could lead to treatment for deadly brain cancer
04/07/2016
High cancer drug costs lead to delays in filling prescriptions, study finds
04/05/2016
MOVING THE FIELD TOWARD MORE PATIENT-FOCUSED DRUG DEVELOPMENT
National Brain Tumor Society`s CEO Named to Cancer Moonshot Initiative`s Blue Ribbon Panel of Experts /h3>
Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio.
04/04/2016
Brain Cancers Reveal Novel Genetic Disruption in DNA
11th SURVIVING BRAIN TUMORS AWARENESS EVENT— MAY 23 & 24, 2016—AT CLEVELAND CLINIC
03/30/2016
IBTA e-News
03/18/2016
LIVE Youtube Streaming TONIGHT! @ 5:30PM PST (8:30 PM Eastern) Patient Education Event for Brain Tumor Patients & Families
03/17/2016
Tocagen to Present at Three Oncology Conferences
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
Ependymoma Awareness Day
03/14/2016
March Madness Brain Cancer Fundraiser in Memory of Wilton Woman’s Sister
03/08/2016
CNY 6-year-old with aggressive cancer beating odds with `superhero` treatment
03/07/2016
Data Safety and Monitoring Board Recommends Celldex`s Phase 3 Study of RINTEGA® (rindopepimut) in Newly Diagnosed Glioblastoma be Discontinued as it is Unlikely to Meet Primary Overall Survival Endpoint in Patients with Minimal Residual Disease
Correction on Celldex article
03/05/2016
The Curcumin Analog C-150, Influencing NF-?B, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo.
03/04/2016
Dbait: An innovative concept to inhibit DNA repair and treat cancer
03/03/2016
Humana Issues Positive Coverage Decision For Optune
02/29/2016
You Can Vote to Help ChadTough Win $100K for DIPG Research